We are preparing the requested document. Please wait, this may take a while...!
|Application / Reactivity||Mouse (Murine)||Human|
|ELISA||47 Antibodies||139 Antibodies|
|Enzyme Immunoassay (EIA)||5 Antibodies||11 Antibodies|
|Flow Cytometry (FACS)||6 Antibodies||13 Antibodies|
|Immunocytochemistry (ICC)||3 Antibodies|
|Immunofluorescence (IF)||4 Antibodies|
|Immunofluorescence (Paraffin-embedded Sections) (IF (p))||24 Antibodies|
|Immunohistochemistry (IHC)||35 Antibodies|
|Immunohistochemistry (Frozen Sections) (IHC (fro))||4 Antibodies|
|Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))||28 Antibodies|
|Immunoprecipitation (IP)||13 Antibodies|
|Western Blotting (WB)||97 Antibodies|
|Cellular Assay (CA)||1 Antibodies|
|ELISA (Capture)||1 Antibodies|
|Immunoassay (IA)||1 Antibodies|
|Immunochromatography (IC)||1 Antibodies|
|Antigen||BH3 Interacting Domain Death Agonist (BID) Antibodies|
|Reactivity||Human, Mouse (Murine) Alternatives|
|Conjugate||This BID antibody is un-conjugated Alternatives|
Enzyme Immunoassay (EIA), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-BID AntibodyTarget Details BID Application Details Handling Images
|Specificity||This antibody reacts to BH3 Interacting Domain Death Agonist (BID).|
Species reactivity (expected):Mouse.
Species reactivity (tested):Human.
|Purification||Ion Exchange Chromatography.|
|Immunogen||Synthetic peptide - KLH conjugated corresponding to 14 amino acids near the carboxy- terminus of Human Bid.|
Target Details BIDProduct Details anti-BID Antibody Application Details Handling Images back to top
|Alternative Name||BID (BID Antibody Abstract)|
|Background||Bid, a BH3 domain containing proapoptotic Bcl2 family member, is localized in the cytosolic fraction of cells as an inactive precursor. Its active form is generated upon proteolytic cleavage by caspase 8 in the Fas signaling pathway. Cleaved Bid translocates to mitochondria and releases its potent proapoptotic activity, which in turn induces cytochrome c release and mitochondrial damage. The cytochrome c releasing activity of Bid was antagonized by Bcl2. Mutation in the SH3 domain can diminish the cytochrome c releasing activity. In animal model studies, Bid deficient mice are found resistant to the lethal effects of death factor signals relayed through Fas.Synonyms: BH3-interacting domain death agonist, p22 BID|
|Pathways||Apoptosis, Caspase Cascade in Apoptosis|
Application DetailsProduct Details anti-BID Antibody Target Details BID Handling Images back to top
ELISA. Western blot: 0.5-1.0 μg/mL. Immunohistochemistry on Frozen Sections: 2 μg/mL. Immunohistochemistry on Paraffin Sections: 5 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.
|Restrictions||For Research Use only|
HandlingProduct Details anti-BID Antibody Target Details BID Application Details Images back to top
|Buffer||PBS containing 0.02 % Sodium Azide as preservative.|
|Precaution of Use||This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Handling Advice||Avoid repeated freezing and thawing.|
|Storage||4 °C/-20 °C|
|Storage Comment||Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.|
ImagesProduct Details anti-BID Antibody Target Details BID Application Details Handling back to top